PHARMA360º

Medicines360 is a mission-driven, nonprofit pharmaceutical company dedicated to expanding access to quality medicines for women, regardless of their socioeconomic status. The company is best known for developing and commercializing LILETTA (levonorgestrel-releasing intrauterine system), a long-acting reversible contraceptive (LARC) that is provided at low cost to public health clinics. Through its for-profit subsidiary, Curae Pharma360, the organization works to ensure the sustainable distribution of its products and addresses shortages in essential women's health medications. Medicines360 operates through a unique model that reinvests proceeds from commercial sales into research and advocacy to further its public health mission.